Get the Stockscreener App
1.09
2.83%
0.03
After Hours:
1.08
-0.01
-0.92%
Inovio Pharmaceuticals Inc stock is traded at $1.09, with a volume of 2.30M.
It is up +2.83% in the last 24 hours and down -34.34% over the past month.
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.
See More
Previous Close:
$1.06
Open:
$1.06
24h Volume:
2.30M
Relative Volume:
1.60
Market Cap:
$88.94M
Revenue:
$65,300
Net Income/Loss:
$-84.95M
P/E Ratio:
-0.5638
EPS:
-1.9332
Net Cash Flow:
$-88.92M
1W Performance:
-3.54%
1M Performance:
-34.34%
6M Performance:
-55.87%
1Y Performance:
-32.30%
1-Day Range:
$1.05
$1.11
1-Week Range:
$1.03
$1.13
52-Week Range:
$1.03
$2.9789
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Name
Inovio Pharmaceuticals Inc
Sector
Industry
Phone
(858) 410-3134
Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
1.09 | 86.49M | 65,300 | -84.95M | -88.92M | -1.9332 |
VRTX
Vertex Pharmaceuticals Inc
|
440.05 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.46 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
809.27 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.00 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
305.64 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-14-24 | Initiated | Stephens | Overweight |
| Jan-25-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-09-22 | Downgrade | Maxim Group | Buy → Hold |
| Nov-01-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-19-22 | Resumed | RBC Capital Mkts | Sector Perform |
| May-11-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-29-21 | Resumed | Jefferies | Hold |
| Sep-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-24-21 | Initiated | Jefferies | Hold |
| Mar-23-21 | Initiated | BofA Securities | Neutral |
| Feb-12-21 | Initiated | Oppenheimer | Outperform |
| Nov-17-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Nov-10-20 | Upgrade | ROTH Capital | Sell → Neutral |
| Sep-28-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-28-20 | Upgrade | Maxim Group | Hold → Buy |
| Jul-01-20 | Downgrade | Maxim Group | Buy → Hold |
| Jul-01-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Jun-29-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-26-20 | Downgrade | Stifel | Buy → Hold |
| May-21-20 | Initiated | The Benchmark Company | Buy |
| Apr-30-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Mar-13-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-13-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-19-19 | Initiated | ROTH Capital | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
| Oct-18-17 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-17 | Initiated | Citigroup | Buy |
| Jun-08-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-24-17 | Reiterated | Maxim Group | Buy |
| Mar-16-17 | Upgrade | Maxim Group | Hold → Buy |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
View All
Inovio Pharmaceuticals Inc Stock (INO) Latest News
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
What's going on with Inovio Pharmaceuticals stock on Tuesday? - MSN
Inovio Pharmaceuticals (INO) price target decreased by 12.21% to 6.90 - MSN
symbol__ Stock Quote Price and Forecast - CNN
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Q4 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Q3 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Q2 2025 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
INO Forecast, Price Target & Analyst Ratings | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill
INOVIO to Present Hemophilia Research at Global Conference - MyChesCo
INO Deadline Today: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit - Sahm
What's Going On With Inovio Pharmaceuticals Stock On Tuesday? - Sahm
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Investor Alert: Deadline in Lawsuit on April 07, 2026 - openPR.com
INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm - PR Newswire
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio (NASDAQ: INO) sets 2026 vote and outlines INO-3107 FDA path - Stock Titan
Inovio Faces Deadline for Shareholder Lawsuit - National Today
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO - FinancialContent
Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders - PharmiWeb.com
DEADLINE ALERT for PSFE, INO, KD: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
INO Shareholder Alert: Investors With Losses May Seek to Lead th - GuruFocus
Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Joplin Globe
INO CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026 - Rutland Herald
INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm - Barchart.com
Inovio Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Inovio Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2026INO - PR Newswire
Pre-market top loser: GBM.F Inovio Pharmaceuticals (XETRA) -34.80% 07 Apr 2026: catalyst timeline key - Meyka
Inovio Faces Class Action Lawsuit Over Regulatory Disclosures - National Today
Bragar Eagel & Squire, P.C. Urgently Reminds Investors that - GlobeNewswire
Inovio prices $17.5 million public offering of shares and warrants - MSN
Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire
Deadline Soon: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - GlobeNewswire
DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - GlobeNewswire
Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point (NASDAQ:INO) - Seeking Alpha
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
INO DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Inovio Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit Today - ACCESS Newswire
Inovio Pharmaceuticals Announces New Public Equity Offering - TipRanks
INO Stockholders Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Inovio Pharmaceuticals Launches $16 Million Stock-and-Warrant Offering Underwritten by Piper Sandler - TradingView — Track All Markets
Inovio (Nasdaq: INO) prices $17.5M stock and dual-warrant public offering - Stock Titan
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, I - GuruFocus
INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. ... - Eagle-Tribune
UNIQURE DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - GlobeNewswire Inc.
INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire
Inovio Pharmaceuticals Faces Stock Dilution and Legal Battles - timothysykes.com
Stock Report: Is Inovio Pharmaceuticals Inc a potential multi baggerQuarterly Earnings Summary & Consistent Profit Trading Strategies - baoquankhu1.vn
Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history - Yahoo Finance UK
INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 - PR Newswire
INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit - Sahm
INO Shareholders Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Inovio Pharmaceuticals Inc Stock (INO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.62%
2.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):